Biblio

Jarry C, Osiurak F, Baumard J, Lesourd M, Coiffard C, Lucas C, Merck C, Etcharry-Bouyx F, Chauvire V, Belliard S et al..  2021.  Daily life activities in patients with Alzheimer's disease or semantic dementia: Multitasking assessment. NEUROPSYCHOLOGIA. 150:107714.

Gueugneau N, Pozzo T, Darlot C, Papaxanthis C.  2017.  DAILY MODULATION OF THE SPEED-ACCURACY TRADE-OFF. NEUROSCIENCE. 356:142-150.

Francois A, Bombail V, Jarriault D, Acquistapace A, Grebert D, Grosmaitre X, Meunier N.  2017.  Daily oscillation of odorant detection in rat olfactory epithelium. EUROPEAN JOURNAL OF NEUROSCIENCE. 45:1613-1622.

Gueugneau N, Schweighofer N, Papaxanthis C.  2015.  Daily update of motor predictions by physical activity. SCIENTIFIC REPORTS. 5:17933.

Winiszewski H, Aptel F, Belon F, Belin N, Chaignat C, Patry C, Clermont C, David E, Navellou J-C, Labro G et al..  2018.  Daily use of extracorporeal CO2 removal in a critical care unit: indications and results. JOURNAL OF INTENSIVE CARE. 6:36.

de Crevoisier R, Bayar MAmine, Pommier P, Muracciole X, Pene F, Dudouet P, Latorzeff I, Beckendorf V, Bachaud J-M, Laplanche A et al..  2018.  Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 102:1420-1429.

de Crevoisier R, Bayar M-A, Pommier P, Muracciole X, Pene F, Dudouet P, Latorzeff I, Beckendorf V, Bachaud J-M, Laplanche A et al..  2018.  Daily versus weekly prostate cancer image-guided radiotherapy: A phase 3, multicenter, randomized trial.. JOURNAL OF CLINICAL ONCOLOGY. 36

de Crevoisier R., Bayar M., Pommier P., Muracciole X., Pene F., Dudouet P., Latorzeff I., Beckendorf V., Bachaud J., Supiot S. et al..  2018.  Daily versus weekly prostate cancer image-guided radiotherapy: A Phase 3 randomized trial. RADIOTHERAPY AND ONCOLOGY. 127:S287.

Moron V, Oueslati B, Pohl B, Janicot S.  2018.  Daily Weather Types in February-June (1979-2016) and Temperature Variations in Tropical North Africa. JOURNAL OF APPLIED METEOROLOGY AND CLIMATOLOGY. 57:1171-1195.

Bereau M, Anheim M, Chanson J-B, Tio G, Echaniz-Laguna A, Depienne C, Collongues N, de Seze J.  2015.  Dalfampridine in hereditary spastic paraplegia: a prospective, open study. JOURNAL OF NEUROLOGY. 262:1285-1288.

Dia A, Dieng L, Gaillet L, Gning PBirame.  2019.  Damage detection of a hybrid composite laminate aluminum/glass under quasi-static and fatigue loadings by acoustic emission technique. HELIYON. 5:e01414.

Rossignol J, Thionnet A.  2014.  Damage in composite material: A Microwave detection. MATERIALS AND APPLICATIONS FOR SENSORS AND TRANSDUCERS III. 605:303-305.

Attouch H, Balhag A, Chbani Z, Riahi H.  2022.  Damped inertial dynamics with vanishing Tikhonov regularization: Strong asymptotic convergence towards the minimum norm solution. JOURNAL OF DIFFERENTIAL EQUATIONS. 311:29-58.

Liu T, Butaud P, Placet V, Ouisse M.  2021.  Damping behavior of plant fiber composites: A review. COMPOSITE STRUCTURES. 275:114392.

Ouisse M, Renault D, Butaud P, Sadoulet-Reboul E.  2019.  Damping control for improvement of acoustic black hole effect. JOURNAL OF SOUND AND VIBRATION. 454:63-72.

Butaud P, Ouisse M, Foltete E.  2016.  DAMPING CONTROL IN A SANDWICH STRUCTURE WITH SMP CORE. ASME CONFERENCE ON SMART MATERIALS, ADAPTIVE STRUCTURES AND INTELLIGENT SYSTEMS, 2015, VOL 1.

Vargas TRivera, Apetoh L.  2017.  Danger signals: Chemotherapy enhancers? IMMUNOLOGICAL REVIEWS. 280:175-193.

Russo D.  2019.  Daniel Russo: Counting for Seeing; Seeing for Counting. The Painted Decorations in the Germolles Chateau from the Period of Philip the Bold and of Margaret of Flanders (end of the 14th century). REVUE DE L ART. :17-23.

Russo D.  2019.  Daniel Russo: Counting for Seeing; Seeing for Counting. The Painted Decorations in the Germolles Chateau from the Period of Philip the Bold and of Margaret of Flanders (end of the 14th century). REVUE DE L ART. :17-23.

Ahouansou N, Georges M, Beltramo G, Aswad N, Hassani Y, Bonniaud P.  2021.  Daptomycin-induced eosinophilic pneumonia: Are there any risk factors? INFECTIOUS DISEASES NOW. 51:618-621.

Boyle EM, Leleu X, Petillon M-O, Karlin L, Doyen C, Demarquette H, Royer B, Macro M, Moreau P, Fostier K et al..  2019.  Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial. BRITISH JOURNAL OF HAEMATOLOGY. 187:319-327.

Vidal-Crespo A, Matas-Cespedes A, Rodriguez V, Rossi C, Valero JG, Serrat N, Sanjuan-Pla A, Menendez P, Roue G, Lopez-Guillermo A et al..  2020.  Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens. HAEMATOLOGICA. 105:1032-1041.

Boyle EMary, Petillon M-O, Herbaux C, Mimouni J, Leleu X, Karlin L, Doyen C, Wetterwald M, Roussel M, Hulin C et al..  2016.  Daratumumab in Combination with Dexamethasone in Resistant or Refractory Multiple Myeloma: Primary Results of the IFM2014-04 Trial. BLOOD. 128

Sonneveld P, Attal M, Perrot A, Hulin C, Caillot D, Facon T, Leleu X, Belhadj K, Karlin L, Benboubker L et al..  2020.  Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTD) in Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-Risk Patients in Cassiopeia. BONE MARROW TRANSPLANTATION. 55:124-126.

Touzeau C, Moreau P, Perrot A, Hulin C, Dib M, Tiab M, Caillot D, Facon T, Leleu X, van de Donk NWCJ et al..  2020.  Daratumumab plus bortezomib, thalidomide, and dexamethasone (D-VTd) in transplant-eligible newly diagnosed multiple myeloma (TE NDMM): Baseline SLiM-CRAB based subgroup analysis of CASSIOPEIA.. JOURNAL OF CLINICAL ONCOLOGY. 38